Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong · Delayed Price · Currency is HKD 5.41
-0.05 (-0.92%)
At close: Feb 13, 2026
38.01% (1Y)
| Market Cap | 18.20B +27.2% |
| Revenue (ttm) | 5.88B -1.0% |
| Net Income | 459.25M |
| EPS | 0.31 |
| Shares Out | n/a |
| PE Ratio | 39.62 |
| Forward PE | n/a |
| Dividend | 0.27 (4.94%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 733,500 |
| Average Volume | 1,017,200 |
| Open | 5.40 |
| Previous Close | 5.46 |
| Day's Range | 5.38 - 5.45 |
| 52-Week Range | 3.82 - 7.26 |
| Beta | 0.49 |
| RSI | 49.52 |
| Earnings Date | Mar 31, 2026 |